ClinicalTrials.Veeva

Menu

Endocan Blood Level in Pulmonary Circulation (ENDOPULM)

C

Centre Hospitalier Universitaire de Besancon

Status

Unknown

Conditions

Cardiac Surgery
Cardiopulmonary Bypass
Lung

Study type

Observational

Funder types

Other

Identifiers

NCT04616820
ENDOPULM

Details and patient eligibility

About

Endocan is a proteoglycan produced by the vascular endothelium. Animal studies suggested that the synthesis mainly happen in the pulmonary circulation, but this hypothesis has never been confirmed in humans.

Full description

The investigators will measure endocan levels in both pulmonary and systemic venous blood in patients undergoing on pump cardiac surgery.

The main objective is to quantify the difference of endocan blood level between the pulmonary and the systemic circulation.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Planned on pump coronary artery bypass surgery
  • Non opposition

Exclusion criteria

  • Age < 18 years old
  • Emergent surgery
  • Valvular replacement surgery
  • Combined cardiac surgery
  • Patients with inflammatory, infectious or evolutive neoplastic pulmonary disease
  • Patients with valvular problems, in particular aortic insufficiency
  • Patients who refuse to participate
  • Legal inability or disability
  • Patients who will probably not cooperate for the study
  • Pregnancy and/or breast feeding
  • Patients not in the Social security system
  • Patients in the exclusion period of another study

Trial contacts and locations

0

Loading...

Central trial contact

Guillaume Besch, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems